EMG
NVRO

Ellington Management Group’s NEVRO CORP. NVRO Stock Holding History

Ellington Management Group’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,800
Closed -$238K – 814
2019
Q1 		$238K Buy
+3,800
New +$179K 0.04% 428
2016
Q4 		– Sell
-2,500
Closed -$261K – 846
2016
Q3 		$261K Buy
+2,500
New +$226K 0.07% 460

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Ellington Management Group's NVRO Position: Q2 2019 in Review

Ellington Management Group sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 3,800 shares — an estimated $238K sold.

Ellington Management Group first reported a position in NVRO in Q3 2016 and held it in 2 quarters. The position peaked at $261K in Q3 2016. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

  • Ellington Management Group reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
  • Ellington Management Group sold 3,800 NEVRO CORP. shares in Q2 2019, an estimated $238K.
  • Ellington Management Group first reported a position in NEVRO CORP. in Q3 2016 and held it in 2 quarters.
  • Ellington Management Group's NEVRO CORP. position peaked at $261K in Q3 2016.
  • 162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Ellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.